Modelon AB (publ) (STO:MODEL)

Market Cap	249.76M
Revenue (ttm)	82.21M
Net Income (ttm)	-56.55M
Shares Out	17.22M
EPS (ttm)	-3.30
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,103
Average Volume	2,023
Open	12.50
Previous Close	13.00
Day's Range	12.50 - 15.00
52-Week Range	9.50 - 19.00
Beta	n/a
RSI	55.54
Earnings Date	Jul 24, 2025

About Revance Therapeutics

Modelon AB (publ) provides systems modeling and simulation software solutions in Sweden and internationally. Its flagship product is Modelon Impact, a cloud-native system simulation software platform with a browser-based interface, and models and components for various applications. The company also offers Modelon Library Suite, a suite of libraries for physical system modeling; and FMI Toolbox for MATLAB/Simulink that supports workflows in control system development and system integration for virtual prototyping. In addition, it provides consu...

• Industry: Computer Programming, Data Processing, And Other Computer Related Services
• Founded: 2004
• Employees: 90
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: MODEL

Financial Performance

In 2024, Modelon AB's revenue was 83.61 million, an increase of 5.84% compared to the previous year's 79.00 million. Losses were -59.45 million, 6.91% more than in 2023.